Your browser doesn't support javascript.
loading
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.
Li, Shao-Hua; Mei, Jie; Cheng, Yuan; Li, Qiang; Wang, Qiao-Xuan; Fang, Chong-Kai; Lei, Qiu-Cheng; Huang, Hua-Kun; Cao, Ming-Rong; Luo, Rui; Deng, Jing-Duo; Jiang, Yu-Chuan; Zhao, Rong-Ce; Lu, Liang-He; Zou, Jing-Wen; Deng, Min; Lin, Wen-Ping; Guan, Ren-Guo; Wen, Yu-Hua; Li, Ji-Bin; Zheng, Lie; Guo, Zhi-Xing; Ling, Yi-Hong; Chen, Huan-Wei; Zhong, Chong; Wei, Wei; Guo, Rong-Ping.
Afiliação
  • Li SH; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Mei J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Cheng Y; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Li Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Wang QX; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Fang CK; Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, P. R. China.
  • Lei QC; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Huang HK; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Cao MR; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P. R. China.
  • Luo R; Department of Hepatopancreatic Surgery, The First People's Hospital of Foshan, Foshan, Guangdong, P. R. China.
  • Deng JD; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Jiang YC; Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, P. R. China.
  • Zhao RC; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P. R. China.
  • Lu LH; Second Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
  • Zou JW; Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, P. R. China.
  • Deng M; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Lin WP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Guan RG; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Wen YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Li JB; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Zheng L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Guo ZX; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Ling YH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Chen HW; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Zhong C; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Wei W; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
  • Guo RP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
J Clin Oncol ; 41(10): 1898-1908, 2023 04 01.
Article em En | MEDLINE | ID: mdl-36525610
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article